Molecular Research on Drug Synthesis and Biological Activity
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (31 August 2024) | Viewed by 3413
Special Issue Editor
Special Issue Information
Dear Colleagues,
To understand the new dimension in drug discovery with better knowledge for the treatment of a disease, extensive recognition of the mechanism of action of a drug can make a huge difference. This is therapeutically important for a disease as well as to improve the concept of side effects associated with a drug. Recognizing a molecular target expands the insight about what we are treating. The challenges associated with the synthesis of a drug are equally important as synthetic steps, structural diversity, metabolized functional groups, lipophilicity, and permeability are the parameters necessary to overcome for the development of a drug.
This Special Issue will approach current challenges in the synthesis of a drug, defining molecular targets, mechanism of action, and biological activity of drugs based on molecular biology. The submission of original articles, short communications, reviews, and clinical trials reporting all the current and past advancement in the diagnosis, investigation, and treatment of a disease associated with a drug at the molecular level are welcome. We look forward to receiving valuable contributions from researchers and academicians all around the world.
Dr. Sushobhan Mukhopadhyay
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug discovery
- biomolecules
- mechanism of action
- biological evaluation
- molecular target
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
